The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Social Issues

Australia to Stop Pharmacists Making DIY Ozempic

Pharmacists have been making copies of weight loss drugs such as Ozempic and Mounjaro, but this is putting patients at risk, according to the TGA.
Australia to Stop Pharmacists Making DIY Ozempic
Joel Sage/AFP via Getty Images
Rex Widerstrom
Rex Widerstrom
5/22/2024|Updated: 5/22/2024
0:00

The Australian government is set to ban pharmacists from compounding replicas of popular weight loss drugs such as Ozempic and Mounjaro, citing safety concerns.

Compounding is a process whereby a pharmacist mixes various ingredients to emulate another drug. It is usually done because the medicine needs to be tailored to suit a particular patient, such as someone who may be allergic to a particular ingredient or needs a different dose than is commercially available.

Rex Widerstrom
Rex Widerstrom
Author
Rex Widerstrom is a New Zealand-based reporter with over 40 years of experience in media, including radio and print. He is currently a presenter for Hutt Radio.
Author’s Selected Articles

Labor Ministers Rally to Defend Sports Minister Over Travel Expense Row

Dec 07, 2025
Labor Ministers Rally to Defend Sports Minister Over Travel Expense Row

Case Against Self-Confessed ‘Extreme’ CCP Supporter Highlights Split in NZ’s Chinese Diaspora

Dec 06, 2025
Case Against Self-Confessed ‘Extreme’ CCP Supporter Highlights Split in NZ’s Chinese Diaspora

Australian Military Tech Supplier Linked to CCP United Front, Inquiry Hears

Dec 05, 2025
Australian Military Tech Supplier Linked to CCP United Front, Inquiry Hears

Beijing Winning the PR War With Megaprojects in Pacific Nation, CEO Warns

Dec 04, 2025
Beijing Winning the PR War With Megaprojects in Pacific Nation, CEO Warns
Related Topics
Australia
FDA - Food and Drug Administration
Therapeutic Goods Administration
Ozempic
compound medicines
Pharmacy Board of Australia
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.